This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 May;365(9472):1665-6.

doi: 10.1016/S0140-6736(05)66524-5.

The 2000 EBCTCG overview: a widening gap

S Chia¹, C Bryce, K Gelmon

Affiliations

PMID: 15894082
DOI: 10.1016/S0140-6736(05)66524-5

Comment

The 2000 EBCTCG overview: a widening gap

S Chia et al. Lancet. 2005 May.

. 2005 May;365(9472):1665-6.

doi: 10.1016/S0140-6736(05)66524-5.

Authors

S Chia¹, C Bryce, K Gelmon

Affiliation

¹ British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada. kgelmon@bccancer.bc.ca

PMID: 15894082
DOI: 10.1016/S0140-6736(05)66524-5

No abstract available

PubMed Disclaimer

Comment on

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2005 May 14-20;365(9472):1687-717. doi: 10.1016/S0140-6736(05)66544-0. Lancet. 2005. PMID: 15894097

Similar articles

[Sensitivity of chemotherapy depending on hormone status in breast cancer].
Ito Y. Ito Y. Nihon Rinsho. 2007 Jun 28;65 Suppl 6:568-71. Nihon Rinsho. 2007. PMID: 17679212 Review. Japanese. No abstract available.
Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.
Higgins MJ, Wolf AC. Higgins MJ, et al. Oncology (Williston Park). 2009 Jan;23(1):40, 42, 44. Oncology (Williston Park). 2009. PMID: 19283920 No abstract available.
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.
Pritchard KI. Pritchard KI. Oncology (Williston Park). 2009 Jan;23(1):27-33. Oncology (Williston Park). 2009. PMID: 19283918 Review.
With maturity comes confidence: EBCTCG tamoxifen update.
Chia SK, Wolff AC. Chia SK, et al. Lancet. 2011 Aug 27;378(9793):747-9. doi: 10.1016/S0140-6736(11)61128-8. Epub 2011 Jul 28. Lancet. 2011. PMID: 21802719 No abstract available.
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A. Dellapasqua S, et al. J Clin Oncol. 2005 Mar 10;23(8):1736-50. doi: 10.1200/JCO.2005.11.050. J Clin Oncol. 2005. PMID: 15755982 Review. No abstract available.

See all similar articles

Cited by

Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Cheng R, Liu YJ, Cui JW, Yang M, Liu XL, Li P, Wang Z, Zhu LZ, Lu SY, Zou L, Wu XQ, Li YX, Zhou Y, Fang ZY, Wei W. Cheng R, et al. Oncotarget. 2017 May 2;8(18):30252-30264. doi: 10.18632/oncotarget.16325. Oncotarget. 2017. PMID: 28415819 Free PMC article.
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy.
Wang J, Chen W, Du W, Zhang H, Ilmer M, Song L, Hu Y, Ma X. Wang J, et al. Int J Nanomedicine. 2023 May 9;18:2389-2409. doi: 10.2147/IJN.S406627. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37192893 Free PMC article.
Breast magnetic resonance imaging: are those who need it getting it?
Tan S, David J, Lalonde L, El Khoury M, Labelle M, Younan R, Patocskai E, Richard J, Trop I. Tan S, et al. Curr Oncol. 2017 Jun;24(3):e205-e213. doi: 10.3747/co.24.3441. Epub 2017 Jun 27. Curr Oncol. 2017. PMID: 28680288 Free PMC article.
Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.
Zhang X, Mu X, Huang O, Xie Z, Jiang M, Geng M, Shen K. Zhang X, et al. PLoS One. 2013 Aug 26;8(8):e72053. doi: 10.1371/journal.pone.0072053. eCollection 2013. PLoS One. 2013. PMID: 23991038 Free PMC article.
Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.
Argano M, De Maria R, Rodlsberger K, Buracco P, Menzies MPL. Argano M, et al. Can J Vet Res. 2019 Apr;83(2):149-153. Can J Vet Res. 2019. PMID: 31097877 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal